\n
Nearly 400 million people globally have asthma, a chronic inflammatory disorder. This common airway issue is characterized by chest tightness, coughing, shortness of breath, tissue remodeling, variable limitation of airflow, and wheezing. In as many as 10% of these patients, asthma is severe and uncontrolled, despite maintaining maximal optimal therapy. Severe asthma is a heterogeneous condition made up of eosinophilic asthma and other phenotypes; however, all patients with severe asthma experience a range of symptoms and medication adverse effects. Early diagnosis and effective management are critical to improve outcomes and quality of life.
\nAre you up-to-date on the latest research on severe asthma treatment, including effective biologics, human monoclonal antibody benefits, and factors associated with higher asthma biologic adherence? Test yourself with this quick quiz.
\n \n \n \n \n \n \nMedscape © 2023 WebMD, LLC
Any views expressed above are the author\'s own and do not necessarily reflect the views of WebMD or Medscape.
\n \n\n Cite this: Mary L. Windle. Rapid Rx Quiz: Severe Asthma Treatment - Medscape - Jun 16, 2023.
\n \r\n[ad_2]\r\n
Source link
